Lilly to Acquire Sigilon Therapeutics, $309.6M
Eli Lilly and Company (NYSE: LLY) and Sigilon Therapeutics, Inc. (Nasdaq: SGTX) announced a definitive agreement for Lilly to acquire Sigilon, a biopharmaceutical company that seek…
Eli Lilly and Company (NYSE: LLY) and Sigilon Therapeutics, Inc. (Nasdaq: SGTX) announced a definitive agreement for Lilly to acquire Sigilon, a biopharmaceutical company that seek…